Buckingham Strategic Wealth LLC Raises Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Buckingham Strategic Wealth LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 10.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 17,734 shares of the healthcare conglomerate’s stock after purchasing an additional 1,638 shares during the period. Buckingham Strategic Wealth LLC’s holdings in UnitedHealth Group were worth $6,929,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also made changes to their positions in UNH. OLD Mission Capital LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $439,000. Camden National Bank lifted its holdings in shares of UnitedHealth Group by 5.5% in the 4th quarter. Camden National Bank now owns 1,902 shares of the healthcare conglomerate’s stock valued at $667,000 after buying an additional 100 shares during the period. Isthmus Partners LLC acquired a new position in UnitedHealth Group during the second quarter worth $48,000. AGF Investments Inc. raised its holdings in UnitedHealth Group by 1.6% during the second quarter. AGF Investments Inc. now owns 524,406 shares of the healthcare conglomerate’s stock worth $209,993,000 after purchasing an additional 8,373 shares during the last quarter. Finally, Employees Retirement System of Texas increased its position in UnitedHealth Group by 2.7% during the second quarter. Employees Retirement System of Texas now owns 176,818 shares of the healthcare conglomerate’s stock worth $70,805,000 after buying an additional 4,705 shares in the last quarter. 86.10% of the stock is currently owned by institutional investors and hedge funds.

Shares of UnitedHealth Group stock traded up $0.45 during trading on Friday, hitting $467.88. 60,621 shares of the stock were exchanged, compared to its average volume of 4,287,067. UnitedHealth Group Incorporated has a 1-year low of $320.35 and a 1-year high of $509.23. The stock has a market capitalization of $440.67 billion, a price-to-earnings ratio of 29.23, a price-to-earnings-growth ratio of 1.51 and a beta of 0.86. The company has a fifty day moving average price of $469.85 and a 200-day moving average price of $435.71. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.59.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, October 14th. The healthcare conglomerate reported $4.52 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $4.41 by $0.11. UnitedHealth Group had a net margin of 5.52% and a return on equity of 23.08%. The firm had revenue of $72.34 billion during the quarter, compared to analysts’ expectations of $71.24 billion. During the same period in the prior year, the company posted $3.51 EPS. The company’s revenue was up 11.1% on a year-over-year basis. Equities research analysts forecast that UnitedHealth Group Incorporated will post 18.84 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 14th. Shareholders of record on Monday, December 6th were paid a $1.45 dividend. This represents a $5.80 dividend on an annualized basis and a dividend yield of 1.24%. The ex-dividend date was Friday, December 3rd. UnitedHealth Group’s dividend payout ratio (DPR) is 35.98%.

UNH has been the subject of a number of research reports. The Goldman Sachs Group initiated coverage on UnitedHealth Group in a research report on Tuesday, December 14th. They set a “buy” rating and a $535.00 price target for the company. Edward Jones initiated coverage on UnitedHealth Group in a research report on Monday. They set a “buy” rating for the company. Credit Suisse Group boosted their price target on UnitedHealth Group from $462.00 to $495.00 and gave the company an “outperform” rating in a research report on Friday, October 15th. Truist boosted their price objective on UnitedHealth Group from $520.00 to $575.00 and gave the stock a “buy” rating in a research note on Wednesday, January 5th. Finally, Oppenheimer boosted their price objective on UnitedHealth Group from $465.00 to $475.00 and gave the stock an “outperform” rating in a research note on Friday, October 15th. Two research analysts have rated the stock with a hold rating, twenty-two have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group has an average rating of “Buy” and an average price target of $500.54.

In other news, Director Stephen J. Hemsley sold 75,000 shares of the business’s stock in a transaction that occurred on Monday, October 25th. The shares were sold at an average price of $448.72, for a total value of $33,654,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Richard T. Burke sold 2,500 shares of UnitedHealth Group stock in a transaction on Tuesday, November 23rd. The stock was sold at an average price of $444.70, for a total transaction of $1,111,750.00. The disclosure for this sale can be found here. 0.55% of the stock is currently owned by company insiders.

About UnitedHealth Group

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Featured Article: Secondary Public Offerings

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.